menu
    • menu

    Company profile for Solara Active Pharma Sciences

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scie...
    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solara Active Pharma Sciencesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road, Guindy, Chennai – 6...
    Telephone
    Telephone
    +91 44 4344 6700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://solara.co.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/solara-active-pharma-sciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI India

    Not Confirmed

    envelop Contact Supplier

    CPhI India

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We’re expanding our CDMO capabilities to meet the next wave of complex therapies, starting with oncology.”

    mic“We’re expanding our CDMO capabilities to meet the next wave of complex therapies, starting with oncology.”

    This week, SpeakPharma interviews Dr. Abdelaziz Toumi, Chief Executive Officer of Lupin Manufacturing Solutions (LMS). With over two decades of global leadership experience in the pharmaceutical and manufacturing sectors, Dr. Toumi has been instrumental in shaping LMS’s transformation into a science-driven, client-centric CDMO. Under his leadership, LMS has expanded into complex APIs, oncology manufacturing, and sustainability-led operations. In this exclusive interview with PharmaCompass, Dr. Toumi shares how the company is reshaping its CDMO strategy to serve the evolving needs of global pharma and biotech clients. He also talks about LMS’s latest milestone — the commissioning of a new dedicated oncology block at its Vizag site as the company strengthens its position in high-potency and complex API development ahead of CPHI Frankfurt. Dr. Abdelaziz, Lupin Manufacturing Solutions has been gaining visibility lately. For those who might not be familiar, how would you describe LMS and its vision within the Lupin Group? LMS represents Lupin’s commitment to extending its scientific excellence and manufacturing quality into the CDMO space. LMS was created with a clear vision to collaborate with innovators, biotech firms, and pharmaceutical companies to accelerate their molecules from development to commercial scale, with the assurance of Lupin’s global quality and compliance standards. In essence, LMS blends Lupin’s heritage of trust with the flexibility and customer-focus of a pure-play CDMO. That’s our DNA. HIGHLIGHTS// Extending scientific excellence to CDMO/assurance of global quality, compliance standards/blending heritage of trust with flexibility, customer focus What makes LMS different in an increasingly competitive global CDMO market? The CDMO industry today is not about who has the largest capacity. Rather, it’s about who brings the most value, scientific innovation and speed to the table. Our edge lies in complex chemistry capabilities, deep regulatory expertise, and a culture built around collaboration and accountability. We focus on areas where precision and containment matter, including highly potent APIs (HPAPIs), oncology, and niche small molecules, and we back that up with teams who think beyond manufacturing, toward solving our clients’ development and commercialization challenges. HIGHLIGHTS// Complex chemistry capabilities/deep regulatory expertise/culture built around collaboration and accountability Dr. Abdelaziz, you mentioned oncology as a key focus area. Can you share more about LMS’s plans in this space? Yes, and I am happy to share this first with PharmaCompass — that we have just commissioned our new oncology block at our Vizag site, which is now operationally ready. This is a major step forward for LMS. The facility has been purpose-built for HPAPIs and oncology APIs, and is equipped with advanced containment systems, over 20 reactors and more than 20 isolators. It has a team of over 100 highly skilled scientists specializing in complex and hazardous chemistries. It expands both our capacity and our confidence to support partners in developing targeted cancer therapies. More importantly, it signals our intent — that we are serious about being a global partner of choice in the oncology CDMO space. HIGHLIGHTS// Commissioned new oncology block at Vizag/facility built for HPAPIs, oncology APIs/equipped with advanced containment systems/100 skilled scientists That’s an exciting development. What opportunities do you see in the oncology manufacturing segment globally? The oncology segment is transforming the pharmaceutical landscape. Globally, it is one of the segments with the highest number of development drugs in the pipeline. With the rise of targeted therapies, potent compounds, and smaller-volume high-value APIs, clients are looking for CDMO partners who combine containment expertise with speed and reliability. We see a strong opportunity here, especially as innovators look to move from lab to commercial scale faster, without compromising safety or compliance. LMS is stepping into this gap with the right infrastructure, people, and mindset to deliver. HIGHLIGHTS// Oncology transforming pharmaceutical landscape/highest number of drugs in pipeline/clients looking for CDMOs in oncology space CPHI Frankfurt is around the corner. What can we expect from LMS this year? This CPHI will be a defining one for us. We will be showcasing LMS as a comprehensive small-molecule CDMO, with a sharpened focus on high-potency and oncology manufacturing. Our conversations in Frankfurt will center around how we can help clients navigate development complexity with the confidence of partnering with a science-first, quality-driven CDMO. People will see a refreshed LMS — one that’s growing fast, innovating continuously, and thinking globally. HIGHLIGHTS// Frankfurt CPHI to be a defining one for LMS/helping clients navigate development complexity with confidence/science-first, quality-driven CDMO Quality and sustainability are gaining importance in CDMO partnerships. How is LMS addressing these dimensions? For us, quality and sustainability are a part of our culture. Every process at LMS is anchored in patient safety, compliance, and continuous improvement. Our regulatory systems are built on Lupin’s decades of global experience, and we are leveraging that legacy in every project we take on. On sustainability, we are investing in green chemistry principles, waste minimization, and energy-efficient operations. We believe responsible manufacturing is not just an ESG statement; it’s good business and essential for long-term trust. HIGHLIGHTS// Quality, sustainability part of culture/processes anchored in patient safety, compliance/regulatory systems built on decades of global experience/investing in sustainability Partnership seems to be a recurring theme for LMS. How do you define a true CDMO partnership? A real partnership starts with shared ambition. We see ourselves not just as a manufacturer, but as an innovation partner working as an extension of our client’s R&D and operations teams. The most successful projects we have delivered are those where we have been involved early, and those that align us on the development strategy, risk management, and commercial readiness. That is what we mean when we say we are building science-led partnerships — these are partnerships that are collaborative, transparent, and outcome-driven. HIGHLIGHTS// Innovation partner working as an extension of clients’ R&D, ops team/need to involve LMS early for successful projects/building science-led partnerships Finally, what is next for LMS as you look beyond this milestone? The oncology block is just the beginning of a larger journey. We are scaling our analytical and development services, peptide synthesis capabilities, adding bioconjugation services, expanding global business development, and investing in digital and automation initiatives to make project execution even more seamless. Our goal is to evolve into a trusted global CDMO partner that combines Lupin’s credibility with next-generation manufacturing and scientific agility. As I like to say – we are not just manufacturing APIs; we are manufacturing trust, innovation, and long-term partnerships. HIGHLIGHTS// Scaling analytical, development services, peptide synthesis capabilities/adding bioconjugation services/expanding global business/investing in digital initiatives 

    Impressions: 1053

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology

    PharmaCompass
    22 Oct 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaPartner in End-to-End API ManufacturingPartner in End-to-End API Manufacturing

    Partner in End-to-End API Manufacturing
    Partner in End-to-End API Manufacturing

    reelPartner in End-to-End API Manufacturing

    This PharmaReel showcases Coral Drugs, a global partner in end-to-end API manufacturing with more than 27 years of expertise. Supported by vertically integrated cGMP and ISO-compliant facilities, the company is backed by USFDA and EMA certifications, patents, and advanced micronization capabilities.

    Impressions: 3480

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    The contract development and manufacturing organization (CDMO) sector has emerged as a key partner in new drug development. This was evident from the strategic investments, partnerships, and expansions witnessed in the third quarter (Q3) of 2025. Several CDMOs, such as Cohance Lifesciences, Fermion Oy, Axplora, AGC Pharma Chemicals invested in new projects. Others, including Veranova, Aenova, and Biosynth, expanded capacities, while Ofichem strengthened its footprint with the acquisition of Avivia BV. CDMOs like Fareva, Evonik, and Samsung Biologics forged strategic partnerships for growth. During Q3, the sector continued to adopt artificial intelligence (AI). This prompted the US Food and Drug Administration (FDA) to issue guidance that recognizes the increasing use of AI and data analytics in drug development.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Cohance, Veranova invest in bioconjugation suites in US; ChemExpress inks ADC deal Earlier this year, Indian drugmaker Suven Pharmaceuticals Limited merged with  leading CDMO Cohance Lifesciences Limited. The merged entity — Cohance Lifesciences — has invested US$ 10 million in a current Good Manufacturing Practice (cGMP) bioconjugation suite at its subsidiary NJ Bio in Princeton, New Jersey.  NJ Bio is executing a major program for an existing innovator client with multiple antibody-drug conjugate (ADC) candidates. Cohance also announced an INR 230 million (approximately US$ 2.58 million) investment in a cGMP oligonucleotide facility at its Hyderabad (India) site. Veranova’s Devens (Massachusetts) site successfully passed a routine FDA cGMP surveillance inspection with a “No Action Indicated” (NAI) classification. Earlier, the company had initiated a US$ 50 million investment to expand its ADC and bioconjugate capabilities at its Devens site. This includes a 9,000-square-foot facility expansion with a new process development lab, two additional cGMP suites, and state-of-the-art bioconjugation development and manufacturing capabilities. These initiatives strengthen the site’s highly potent API (HPAPI) and ADC development and manufacturing capabilities. Biosynth has expanded its Berlin facility with a new GMP bioconjugation suite. The expansion supports the company’s manufacturing capabilities in conjugate vaccines, conjugate drugs, activated polyethylene glycol (PEGs), and polymer-based drug delivery excipients. ChemExpress, Mabwell Bioscience, and Insilico Medicine have entered into a strategic partnership to jointly develop a large ADC compound library and advance next-generation ADC candidates. The collaboration combines Mabwell’s antibody and ADC technology, Insilico’s AI-powered drug design platform, and ChemExpress’s expertise in linker-payload chemistry. Together, they aim to build a complete, AI-driven ADC development model that accelerates discovery, optimization, and commercialization. This partnership is expected to enhance R&D efficiency and deliver safer, more effective cancer treatments.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Fermion, Axplora, Aenova increase API manufacturing capacities; ICE Pharma expands India facility Finnish CDMO Fermion Oy has launched a renovation project at its Hanko (Finland) production site to modernize its API manufacturing capabilities. This expansion is part of Fermion's broader strategy to increase production, enhance flexibility in the manufacturing of both existing and future pharmaceutical products, and enable potential contract manufacturing opportunities. German CDMO Axplora has announced a €6.5 million (approximately US$ 7.5 million) investment to expand its API manufacturing capacity at its Vizag site in India. This expansion aims to strengthen both production capabilities and supply chain resilience. India-based Aarti Pharmalabs has inaugurated the first phase of its greenfield manufacturing facility in Gujarat (India). This expansion aims to bolster Aarti's CDMO and contract manufacturing organization (CMO) services, targeting a revenue goal of INR 10 billion (approximately US$ 112 million). Snapdragon Chemistry, which was acquired by Cambrex in 2023, has expanded its Massachusetts facility to better support peptide drug development and manufacturing. With this upgrade, the company can now handle peptide projects from early development through full-scale manufacturing. Italy-headquartered ICE Pharma has expanded its Raichem facility in India. The new facility will enhance the production of ursodeoxycholic acid (UDCA), an API it derives from chicken bile. This expansion increases the site’s raw UDCA output by 120 metric tons annually. Spain-headquartered AGC Pharma Chemicals inaugurated a new advanced manufacturing plant in Barcelona, with an investment of €110 million (approximately US$ 128.3 million). The plant spans 7,500 square meters and integrates cutting-edge technologies to support the entire drug development lifecycle — from R&D to commercial manufacturing. This represents a 30 percent increase in the company’s production capacity and introduces a segment dedicated to HPAPIs. Germany-headquartered Aenova has launched a new hot melt extrusion platform at its Regensburg (Germany) site. This new equipment enables the production of advanced drug formulations, while handling all testing and quality checks in-house. The move strengthens Aenova’s capabilities in developing and manufacturing complex medications. US-based Cytovance Biologics has introduced in-house formulation development services, enhancing its role as a comprehensive partner for biologic drug developers. These services utilize quality-by-design principles to ensure speed, safety, and precision in current and future client programs.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Ofichem acquires Avivia BV; Evonik, Samsung Biologics form strategic collaborations Europe-based CDMO Ofichem Group announced the acquisition of Avivia BV, a formulation development company in the Netherlands. This acquisition is part of Ofichem’s strategy to become a fully integrated provider of development solutions across both drug substance and drug product, with a focus on complex formulations. Ofichem has also acquired Meribel Pharma Solutions’ site in Uppsala (Sweden) to strengthen its support for biotech innovators and expand its presence in the Nordic region.  Simtra BioPharma Solutions has acquired a 65-acre property near its Bloomington, Indiana (US) facility, adding over 300,000 square feet of potential expansion space. With this site, Simtra now has the flexibility to rapidly expand in the US. German specialty chemicals company Evonik is partnering with German biotech Ethris to develop and commercialize a next-generation lipid nanoparticle (LNP) platform for delivering nucleic acid therapies. Evonik will assist in formulation using Ethris’ SNaP LNP technology. The LNP market alone is projected to grow to US$2.3 billion by 2032. Luxembourg-headquartered Fareva has partnered with Zhaoke Ophthalmology to expand its footprint in China’s pharma market. Zhaoke will act as Fareva’s go-to partner for customers seeking pharmaceutical manufacturing in China. Samsung Biologics has signed a 1.8 trillion won (US$ 1.3 billion) manufacturing agreement with an undisclosed US-based drugmaker. And UK-based eXmoor Pharma has partnered with Anthony Nolan to provide end-to-end services for cell therapy developers.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Our view The global CDMO market, valued at around US$ 255 billion in 2025, is projected to grow to over US$ 465 billion by 2032. Significantly, about 60 percent of new drug approvals in the US and over 65 percent in Europe now involve CDMO support. The developments outlined above underscore the increasing role CDMOs are playing today in bringing about growth and innovation in the pharmaceutical industry.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1680

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

    #PharmaFlow by PHARMACOMPASS
    16 Oct 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Solara Active Pharma Sciences Q1FY26 Pat Surges to Rs. 10.52 Cr
    Solara Active Pharma Sciences Q1FY26 Pat Surges to Rs. 10.52 Cr

    26 Jul 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-consolidated-q1fy26-pat-rises-to-rs-1052-cr-17471

    INDPHARMAPOST
    26 Jul 2025
    Share Share
    Solara Active Pharma Sciences reports Rs. 2.10 Cr Q4 FY25 loss
    Solara Active Pharma Sciences reports Rs. 2.10 Cr Q4 FY25 loss

    18 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-posts-q4-fy25-consolidated-loss-at-rs-210-cr-17174

    INDPHARMAPOST
    18 May 2025
    Share Share
    Solara Active Pharma reports profit of Rs 8.09 cr in Dec quarter
    Solara Active Pharma reports profit of Rs 8.09 cr in Dec quarter

    24 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/solara-active-pharma-sciences-reports-consolidated-net-profit-of-rs-8-09-crore-in-the-december-2024-quarter-125012401035_1.html

    BUSINESS STD
    24 Jan 2025
    Share Share
    Solara Active Pharma Sciences Ltd Surges 2.77%
    Solara Active Pharma Sciences Ltd Surges 2.77%

    07 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/solara-active-pharma-sciences-ltd-surges-2-77-125010700198_1.html

    BUSINESS STD
    07 Jan 2025
    Share Share
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr

    23 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-consolidated-q2-fy25-net-profit-at-rs-801-cr-16351

    INDPHARMAPOST
    23 Oct 2024
    Share Share
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr

    23 Jul 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-q1-fy25-consolidated-loss-at-rs-1346-cr-15903

    INDIANPHARMAPOST
    23 Jul 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Aprepitant

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Aprepitant

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29215

    Submission : 2015-03-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-033 - Rev 00

    Issue Date : 2025-01-15

    Type : Chemical

    Substance Number : 2757

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 305MF10125

    Registrant's Address : 2nd Floor, Admin Block 27, Vandalooor kelambakkam Road, Keelakottaiyur Village, Melakottaiyur PO, Chennai 600 127 Tamilna

    Initial Date of Registration : 2023-11-29

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2025-09-29

    Valid Till : 2028-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-020

    Start Marketing Date : 2020-02-20

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Levetiracetam

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Levetiracetam

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2020-06-12

    Pay. Date : 2020-02-20

    DMF Number : 26500

    Submission : 2012-09-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2012-324 - Rev 02

    Issue Date : 2024-10-21

    Type : Chemical

    Substance Number : 2535

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 302MF10081

    Registrant's Address : 2nd Floor, Admin Block 27, Vandalooor kelambakkam Road, Keelakottaiyur Village, Melakottaiyur PO, Chennai 600 127 Tamilna

    Initial Date of Registration : 2020-07-09

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2025-09-29

    Valid Till : 2028-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-025

    Start Marketing Date : 2020-07-16

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Farm & Biz Co., Ltd.

    Registration Date : 2020-07-29

    Registration Number : 20141010-183-I-403-22(2)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A1/B, Sipcot Industrial Complex, Kudikadu Village Cuddalore-607 005, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Oseltamivir Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Oseltamivir Phosphate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-10-21

    Pay. Date : 2015-09-08

    DMF Number : 22926

    Submission : 2009-07-08

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2015-348 - Rev 03

    Issue Date : 2025-09-29

    Type : Chemical

    Substance Number : 2422

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 305MF10097

    Registrant's Address : No 120 A&B, 36, 120P & 121, Industrial Area, Baikampady, New Mangalore - 575011, Karnataka, India

    Initial Date of Registration : 2023-08-22

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2024-05-29

    Valid Till : 2027-03-04

    Written Confirmation Number : WC-0294

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-004

    Start Marketing Date : 2011-01-30

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Masung LS Co., Ltd.

    Registration Date : 2020-07-02

    Registration Number : 20190718-209-J-179(5)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : 120 A&B, 120P & 121, Industrial Area Baikampady New Mangalore – 575 011, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Dextromethorphan Hydrobromide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Dextromethorphan Hydrobromide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 26762

    Submission : 2012-12-26

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-288 - Rev 00

    Issue Date : 2022-06-28

    Type : Chemical

    Substance Number : 20

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-09-29

    Valid Till : 2028-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Gabapentin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Gabapentin

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-10-26

    Pay. Date : 2012-12-03

    DMF Number : 17543

    Submission : 2004-07-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2011-154 - Rev 03

    Issue Date : 2023-09-07

    Type : Chemical

    Substance Number : 2173

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-09-29

    Valid Till : 2028-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-014

    Start Marketing Date : 1993-12-30

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Farm East Co., Ltd.

    Registration Date : 2018-07-30

    Registration Number : 20130503-142-I-210-18(13)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A1/B, Sipcot Industrial Complex, Kudikadu Village Cuddalore-607 005, Tamil Nadu, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Hydralazine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Hydralazine Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-07

    Pay. Date : 2013-01-02

    DMF Number : 22633

    Submission : 2009-03-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2013-191 - Rev 03

    Issue Date : 2024-06-26

    Type : Chemical

    Substance Number : 829

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2024-05-29

    Valid Till : 2027-03-04

    Written Confirmation Number : WC-0294

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-001

    Start Marketing Date : 2011-01-30

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Nizatidine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Nizatidine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13192

    Submission : 1998-09-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2000-083 - Rev 10

    Issue Date : 2023-12-19

    Type : Chemical

    Substance Number : 1453

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-09-29

    Valid Till : 2028-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-018

    Start Marketing Date : 1988-04-12

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : AL Pharma Co., Ltd.

    Registration Date : 2025-04-16

    Registration Number : 20130507-144-I-204-04(A)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A1/B, Sipcot Industrial Complex Kudikadu Cuddalore - 607 005, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Olanzapine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Olanzapine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2021-07-13

    Pay. Date : 2021-07-09

    DMF Number : 18260

    Submission : 2005-04-08

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2012-050 - Rev 04

    Issue Date : 2025-07-31

    Type : Chemical

    Substance Number : 2258

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-09-29

    Valid Till : 2028-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-023

    Start Marketing Date : 2020-05-25

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharma Solution Co., Ltd.

    Registration Date : 2024-08-26

    Registration Number : 20210721-209-J-1041(1)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A1/B, SIPCOT Industrial Complex, Kudikadu, Cuddalore- 607 005, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Praziquantel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Praziquantel

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-11-04

    Pay. Date : 2016-09-19

    DMF Number : 26076

    Submission : 2012-05-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2021-162 - Rev 00

    Issue Date : 2025-04-25

    Type : Chemical

    Substance Number : 855

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2024-05-29

    Valid Till : 2027-03-04

    Written Confirmation Number : WC-0294

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-005

    Start Marketing Date : 2011-01-30

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Succinylcholine Chloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AIChE Annual Meeting
    Not Confirmed
    arrow

    Succinylcholine Chloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AIChE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-03-31

    Pay. Date : 2014-03-18

    DMF Number : 22892

    Submission : 2009-06-24

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2013-210 - Rev 01

    Issue Date : 2024-05-30

    Type : Chemical

    Substance Number : 248

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2024-05-29

    Valid Till : 2027-03-04

    Written Confirmation Number : WC-0294

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-002

    Start Marketing Date : 2011-12-01

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Analytical

    Click here to discover the service providers for Analytical

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Solara Active Pharma Sciences and get a quotation

    Solara Active Pharma Sciences is a supplier offers 132 products (APIs, Excipients or Intermediates).

    Find a price of Aprepitant bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Levetiracetam bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Oseltamivir Phosphate bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Bumetanide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Buspirone Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Celecoxib bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Colchicine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan Hydrobromide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Dipyridamole bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Etomidate bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Flecainide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Gabapentin bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Hydralazine Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mesalazine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Mesna bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Nizatidine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Olanzapine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Praziquantel bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Succinylcholine Chloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Sulfiram bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Mofetil bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Brivaracetam bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Carisoprodol bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Colesevelam Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Cycloserine bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Edaravone bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ethacrynic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Imiquimod bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Isradipine bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ketoprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Lurasidone Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mefenamic Acid bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Methohexital bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Methoxsalen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mirabegron bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Sodium bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Obeticholic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Pitavastatin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Posaconazole bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Pregabalin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Rifaximin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Rotigotine bulk with DMF, JDMF offered by Solara Active Pharma Sciences

    Find a price of Safinamide Methanesulfonate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Carbonate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Zileuton bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Fluocytosine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Loratadine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pentoxifylline bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Ranitidine bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Sapropterin Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Tioconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acitretin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acyclovir Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Albendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artemether bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artesunate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Atracurium Besylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Buspirone Hydrochloride bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Chlorphenesin bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Chlorpromazine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Chlorthalidone bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Citicoline Sodium bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Clomipramine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Colestipol bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Efinaconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ertapenem bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Erythromycin Ethyl Succinate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Felbamate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Indomethacin Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Iron Sucrose bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Labetalol Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lumefantrine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mebendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mefenamic Acid bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Meprobamate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mesalazine bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Midazolam bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Milnacipran Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pantoprazole Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Patiromer Sorbitex Calcium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sodium Zirconium Cyclosilicate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Succinylcholine Chloride bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Sugammadex Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ursodeoxycholic Acid bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Zidovudine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Cinacalcet Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Quinapril bulk offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Sulfasalazine bulk offered by Solara Active Pharma Sciences

    Find a price of Carbidopa bulk offered by Solara Active Pharma Sciences

    Find a price of Choline Chloride bulk offered by Solara Active Pharma Sciences

    Find a price of Edoxaban Tosylate bulk offered by Solara Active Pharma Sciences

    Find a price of Favipiravir bulk offered by Solara Active Pharma Sciences

    Find a price of Gabapentin bulk offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Iron Sucrose bulk offered by Solara Active Pharma Sciences

    Find a price of Levetiracetam bulk offered by Solara Active Pharma Sciences

    Find a price of Levodopa bulk offered by Solara Active Pharma Sciences

    Find a price of Loxoprofen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Migalastat bulk offered by Solara Active Pharma Sciences

    Find a price of Nizatidine bulk offered by Solara Active Pharma Sciences

    Find a price of Olanzapine bulk offered by Solara Active Pharma Sciences

    Find a price of Oseltamivir Phosphate bulk offered by Solara Active Pharma Sciences

    Find a price of Patiromer bulk offered by Solara Active Pharma Sciences

    Find a price of Pitavastatin bulk offered by Solara Active Pharma Sciences

    Find a price of Sertraline Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Carbonate bulk offered by Solara Active Pharma Sciences

    Find a price of Tasimelteon bulk offered by Solara Active Pharma Sciences

    Find a price of Tranexamic Acid bulk offered by Solara Active Pharma Sciences

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search